Filing Details

Accession Number:
0001127602-13-007807
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-25 17:03:35
Reporting Period:
2013-02-22
Filing Date:
2013-02-25
Accepted Time:
2013-02-25 17:03:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
799729 Parexel International Corp PRXL Services-Commercial Physical & Biological Research (8731) 042776269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1083208 J Patrick Fortune Cleveland Clinic Foundation
9500 Euclid Ave/Gcic-10
Cleveland OH 44195
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-22 3,336 $9.69 32,518 No 4 M Direct
Common Stock Disposition 2013-02-22 3,336 $34.01 29,182 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-02-22 3,336 $0.00 3,336 $9.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-09-01 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $33.95-$34.04. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
  2. Currently exercisable